Neuroprotective effect of long-term NDI1 gene expression in a chronic mouse model of Parkinson disorder.
about
No immune responses by the expression of the yeast Ndi1 protein in ratsSuccessful amelioration of mitochondrial optic neuropathy using the yeast NDI1 gene in a rat animal modelNicotinamide, NAD(P)(H), and Methyl-Group Homeostasis Evolved and Became a Determinant of Ageing Diseases: Hypotheses and Lessons from PellagraMitochondrial dysfunction in the striatum of aged chronic mouse model of Parkinson's disease.Expression of zinc-deficient human superoxide dismutase in Drosophila neurons produces a locomotor defect linked to mitochondrial dysfunction.Essential role of TID1 in maintaining mitochondrial membrane potential homogeneity and mitochondrial DNA integrity.Protective Role of rAAV-NDI1, Serotype 5, in an Acute MPTP Mouse Parkinson's Model.Neuroprotective effects and mechanisms of exercise in a chronic mouse model of Parkinson's disease with moderate neurodegeneration.Melatonin protects against neurobehavioral and mitochondrial deficits in a chronic mouse model of Parkinson's diseaseMitochondrial complex I activity and NAD+/NADH balance regulate breast cancer progression.AIF, reactive oxygen species, and neurodegeneration: a "complex" problemGene-based therapies in Parkinson's disease.Antioxidant gene therapy against neuronal cell death.The approaches for manipulating mitochondrial proteomeMitochondrial medicine: to a new era of gene therapy for mitochondrial DNA mutations.Gene therapy: a viable therapeutic strategy for Parkinson's disease?Expression of yeast NDI1 rescues a Drosophila complex I assembly defect.Studying Huntington's Disease in Yeast: From Mechanisms to Pharmacological Approaches
P2860
Q27317060-1A4A7F38-EFC2-40F3-B226-CFD3231EC7A3Q27324143-223D89EE-005A-4D8B-8ABE-AF420B1BD0F7Q28730781-FC4A6D90-D136-4F11-B51B-BDD647A7B62AQ33868426-01B32DF7-835A-4E3E-A413-3C23D36929ACQ34092213-9A37EFE1-336D-4404-B368-23FF8DC6B9F3Q34402031-BCC41D62-5782-4CEF-985C-03C095E71D02Q34423923-8E84BE27-DA9A-48C9-AED4-3DB5BF51BAB3Q34812895-BC6FDC2C-AFF1-4DA9-9000-FF88A4E2DDDCQ35165389-4572CED2-32B8-409A-A4F1-8CF0C2D69E56Q36638143-62507CFF-5CC1-4A6E-A087-7B08C9903FE1Q36724691-C0C477BE-5642-41FF-B0AB-38043E5A76D6Q37506503-DF12880F-AC64-4EEB-964C-906F49ADED1BQ37647941-5343E977-D398-49FB-85F2-DED3A6B99244Q37764798-D9D35A54-2C31-468B-BCD1-63594258830BQ37767167-FCC24E6E-A3D0-41F3-96F0-7451E7F4D18CQ37801855-A77E3A63-3AB4-45BE-A898-8093419F7528Q41776705-BFD60B22-21BF-43AE-89FE-98E3C8995A94Q58764761-C69F22FF-E0A9-4146-B501-0664B6672DF1
P2860
Neuroprotective effect of long-term NDI1 gene expression in a chronic mouse model of Parkinson disorder.
description
2009 nî lūn-bûn
@nan
2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Neuroprotective effect of long ...... e model of Parkinson disorder.
@ast
Neuroprotective effect of long ...... e model of Parkinson disorder.
@en
Neuroprotective effect of long ...... e model of Parkinson disorder.
@nl
type
label
Neuroprotective effect of long ...... e model of Parkinson disorder.
@ast
Neuroprotective effect of long ...... e model of Parkinson disorder.
@en
Neuroprotective effect of long ...... e model of Parkinson disorder.
@nl
prefLabel
Neuroprotective effect of long ...... e model of Parkinson disorder.
@ast
Neuroprotective effect of long ...... e model of Parkinson disorder.
@en
Neuroprotective effect of long ...... e model of Parkinson disorder.
@nl
P2093
P2860
P356
P1476
Neuroprotective effect of long ...... e model of Parkinson disorder.
@en
P2093
Akemi Matsuno-Yagi
Byoung Boo Seo
Eiko Nakamaru-Ogiso
Jennifer Barber-Singh
Takao Yagi
Yuen-Sum Lau
P2860
P304
P356
10.1089/REJ.2009.0854
P407
P577
2009-08-01T00:00:00Z